학술논문

Safety and efficacy of trastuzumab biosimilar plus irinotecan or gemcitabine in patients with previously treated HER2 (ERBB2)-positive non-breast/non-gastric solid tumors: a phase II basket trial with circulating tumor DNA analysis
Document Type
Article
Source
In ESMO Open June 2023 8(3)
Subject
Language
ISSN
2059-7029